Lmr Partners LLP Eli Lilly & CO Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Lmr Partners LLP holds 45,000 shares of LLY stock, worth $33.9 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

45,000

Previous 499 8918.04%

Holding current value

$33.9 Million

Previous $451,000 8739.69%

% of portfolio

0.37%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $2.91 Million - $3.62 Million	3,769 Added 755.31%	4,268 $3.78 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $3.58 Million - $4.48 Million	-4,932 Reduced 90.81%	499 $451,000
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $3.22 Million - $4.3 Million	5,431 New	5,431 $4.23 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $6.15 Million - $7.22 Million	-19,783 Reduced 40.34%	29,261 $10 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $15.8 Million - $18.4 Million	49,044 New	49,044 $17.9 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5.35 Million - $6.64 Million	-23,789 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.97 Million - $6.12 Million	22,442 Added 1666.07%	23,789 $5.5 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $56,331 - $72,864	-312 Reduced 18.81%	1,347 $309,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $272,606 - $352,902	1,659 New	1,659 $310,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $4.51 Million - $5.22 Million	-30,867 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $4.21 Million - $5.07 Million	30,867 New	30,867 $5.07 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $1.22 Million - $1.51 Million	-11,381 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $2.23 Million - $2.43 Million	-20,901 Reduced 64.75%	11,381 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $3.58 Million - $4.17 Million	32,282 New	32,282 $3.58 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $2.96 Million - $3.49 Million	-26,631 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.82 Million - $3.16 Million	26,631 New	26,631 $3.08 Million
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $383,233 - $411,061	-4,677 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $360,456 - $400,070	4,677	4,677 $400,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account